Drug Profile
Propofol spray - Manhattan Pharmaceuticals/NovaDel Pharma
Alternative Names: Propofol lingual spray; Propofol LSLatest Information Update: 06 Nov 2021
Price :
$50
*
At a glance
- Originator Manhattan Pharmaceuticals; NovaDel Pharma
- Developer Manhattan Pharmaceuticals
- Class General anaesthetics; Phenols; Small molecules
- Mechanism of Action GABA receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Sedation
Most Recent Events
- 27 Aug 2009 Propofol spray is still available for licensing (http://www.manhattanpharma.com)
- 11 Feb 2008 Propofol spray is available for licensing (http://manhattanpharma.com)
- 01 Feb 2005 The FDA accepted Manhattan Pharmaceuticals IND for propofol lingual spray